www.g4media.ro/studiu-picaturile-nazale-experiment
Researchers at the University of Sydney have developed experimental nasal drops that enhance learning and memory in aging mice, potentially preventing memory loss associated with Alzheimer's disease. This treatment utilizes messenger RNA (mRNA) technology, similar to that used in COVID-19 vaccines. The study, led by Professor Greg Neely, suggests a new approach to treating neurological conditions by allowing therapeutic proteins to reach the brain non-invasively. The nasal drops improved cognitive functions in older mice, restoring their abilities to levels seen in younger mice. The research indicates that increasing brain-derived neurotrophic factor (BDNF) levels could support neuronal health without reducing amyloid plaques, which are typically targeted in Alzheimer's treatments. Future studies will focus on optimizing this delivery system and assessing its long-term safety and efficacy for potential clinical trials.
Fact-check this story: paste the text or link into Justificat.ro and get a verdict with the sources consulted.